Net profit of Godavari Drugs rose 82.09% to Rs 1.22 crore in the quarter ended December 2023 as against Rs 0.67 crore during the previous quarter ended December 2022. Sales rose 10.09% to Rs 43.11 crore in the quarter ended December 2023 as against Rs 39.16 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales43.1139.16 10 OPM %8.175.80 - PBDT2.301.47 56 PBT1.800.96 88 NP1.220.67 82 Powered by Capital Market - Live News

Godavari Drugs has revised the meeting of the Board of Directors which was scheduled to be held on 14 February 2024. The meeting will now be held on 13 February 2024.Powered by Capital Market - Live News

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Net profit of Godavari Drugs remain constant at Rs 0.86 crore in the quarter ended September 2023 and also during the previous quarter ended September 2022. Sales declined 2.49% to Rs 39.54 crore in the quarter ended September 2023 as against Rs 40.55 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales39.5440.55 -2 OPM %7.766.34 - PBDT1.771.64 8 PBT1.281.17 9 NP0.860.86 0 Powered by Capital Market - Live News

Net profit of Godavari Drugs declined 11.96% to Rs 0.81 crore in the quarter ended June 2023 as against Rs 0.92 crore during the previous quarter ended June 2022. Sales declined 16.76% to Rs 35.42 crore in the quarter ended June 2023 as against Rs 42.55 crore during the previous quarter ended June 2022. ParticularsQuarter Ended�Jun. 2023Jun. 2022% Var. Sales35.4242.55 -17 OPM %6.355.62 - PBDT1.591.72 -8 PBT1.121.26 -11 NP0.810.92 -12 Powered by Capital Market - Live News